my mid-year synopsis of AST - 2018 | AST Message Board Posts

Asterias Biotherapeutics, Inc.

  AST website

AST   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  123 of 136  at  6/30/2018 6:40:38 PM  by

tetrimbath


my mid-year synopsis of AST - 2018

INTRO Here's my semi-annual exercise to see if I remember why I own the stocks I own, and so I can check back and see if their stories have changed. I post in case it helps others too.


Asterias

AST (market cap is $0.074B was $0.122B)

Asterias is a speculative biotech company advancing innovations in treatments that are subsequently high risk, and hopefully promising high rewards. Their most publicized treatment is a way to help damaged nerves regrow. This treatment is targeted at accident victims who have lost some or all motor skills in limbs. Their other major initiatives are cancer vaccines based on managing telomerase. Regaining motor skills is easier to demonstrate, which may be why the company is primarily identified with that treatment.


The progress is encouraging. Some patients have regained motor control, and the cancer vaccines are proceeding. All of the treatments are aimed at large, unmet needs.


A major caution with innovative biotechnology companies and their treatments is that the FDA is not as innovative in its approval process. Of the three main clinical trial phases, Asterias’ are only in phases 1 and 2. Phase 3 is yet to conclude, and then the approval process begins. Unless the FDA decides to accelerate the process on compassionate grounds, public treatments and subsequent profits are many years away.


DISCLOSURE LTBH by habit, but only holding the shares since 2014. I bought more because I am pleased with their progress, but am cautious about dilution.

(I've also collected links to the other discussion boards and my other stocks over on my blog http://trimbathcreative.wordpress.com/2018/06/30/semi-annual-exercise-Mid-2018/)




     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 366
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...